Moreover, the mRNA levels of csf2ra and cd43 were significantly lower in the tumor tissues of mice bearing 4T1 (Figure 7G and Supplementary Figure 9B) and LLC (Figure 7H and Supplementary Figure 9C) tumors after treatment with the combination of 5-aza-dC and TSA than those seen upon either therapy alone. This evidence concerns the gene CSF2RA and neoplasm.